Burlingame, CA, United States of America

James William Janc

USPTO Granted Patents = 3 

Average Co-Inventor Count = 15.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
3 patents (USPTO):

Title: The Innovations of James William Janc

Introduction

James William Janc is a notable inventor based in Burlingame, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of cysteine protease inhibitors. With a total of 3 patents, Janc's work has implications for treating diseases such as osteoporosis.

Latest Patents

One of Janc's latest patents focuses on cathepsin cysteine protease inhibitors. This invention relates to a novel class of compounds that serve as inhibitors of cathepsins K, L, S, and B. These compounds are particularly useful for treating diseases where inhibition of bone resorption is indicated, such as osteoporosis. The innovative nature of these compounds highlights Janc's commitment to advancing medical science.

Career Highlights

Throughout his career, Janc has worked with prominent companies in the pharmaceutical industry. He has been associated with Axys Pharmaceuticals, Inc. and Merck Canada Inc. His experience in these organizations has allowed him to contribute to significant advancements in drug development.

Collaborations

Janc has collaborated with various professionals in his field, including Cameron Black and Serge Leger. These partnerships have enriched his work and expanded the impact of his inventions.

Conclusion

James William Janc's contributions to the field of biochemistry through his innovative patents and collaborations demonstrate his dedication to improving healthcare solutions. His work continues to influence the treatment of diseases related to bone resorption.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…